Dermatology
| Psoriasis
Dermatology
Psoriasis
PsoBest: Current status, profiles, impact for health care of the erman National Registry on Psoriasis
book_2
Source:
EADV Virtual - Poster session
calendar_today
Published on Medfyle:
November 2020
headphones
2
min
This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.
Key messages
- PsoBest is a non-intervention registry that aims to collect long-term evidence of the safety and effectiveness of systemic therapies for psoriasis.
- Over the past 12 years, 14,177 patients have been included, with 7,854 patient-years of biologic treatment and 9,147 on other treatments.
- The most common biologics prescribed are adalimumab and ustekinumab.
- The most common conventional systemics are fumaric acid esters and methotrexate.
Presenting Author
Read more
arrow_downward
Hide
arrow_upward
Laura Kühl
Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Germany